High YKL-40 serum concentration is correlated with prognosis of Chinese patients with breast cancer (Q34507263)

2 August 2017

High YKL-40 serum concentration is correlated with prognosis of Chinese patients with breast cancer (English)

1 reference

2 August 2017

1 reference

Dong Wang

1

1 reference

2 August 2017

Bo Zhai

2

1 reference

2 August 2017

Fengli Hu

3

1 reference

2 August 2017

Chang Liu

4

1 reference

2 August 2017

Jinpeng Zhao

5

1 reference

2 August 2017

Jun Xu

6

1 reference

2 August 2017

language of work or name

English

0 references

publication date

5 December 2012

1 reference

2 August 2017

1 reference

2 August 2017

7

1 reference

2 August 2017

12

1 reference

2 August 2017

e51127

1 reference

Creative Commons Attribution 4.0 International

2 August 2017

start time

5 December 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515550

Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515550

A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515550

7 July 2018

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515550

Plasma YKL-40: a potential new cancer biomarker?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515550

YKL-40, a secreted glycoprotein, promotes tumor angiogenesis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515550

Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515550

High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515550

Serum YKL-40 and colorectal cancer.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515550

Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515550

Increased tissue immunoexpression of YKL-40 protein in high grade serous ovarian cancers

7 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0051127

Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0051127

Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0051127

YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0051127

YKL-40 expression in human hepatocellular carcinoma: a potential biomarker?

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515550

Overexpression of YKL-40 is an independent prognostic marker in gastric cancer

27 October 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0051127

YKL-40 protein levels and clinical outcome of human endometrial cancer

21 January 2018

1 reference

12 December 2020

High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer

1 reference

12 December 2020

Serum YKL-40: A new potential marker of prognosis and location of métastases of patients with recurrent breast cancer

1 reference

12 December 2020

Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer

1 reference

12 December 2020

Increased expression of the inflammatory protein YKL-40 in precancers of the breast

1 reference

12 December 2020

Plasma YKL-40 levels in healthy subjects from the general population

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0051127

Identifiers

DOI

1 reference

2 August 2017

0 references

1 reference

2 August 2017

1 reference